Val­ne­va re­ceives first chikun­gun­ya vac­cine ap­proval af­ter two month de­lay to FDA re­view

Val­ne­va re­ceived the first reg­u­la­to­ry ap­proval for a chikun­gun­ya virus vac­cine with an FDA ac­cel­er­at­ed nod on Thurs­day night.

The green …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA